Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
ByHeart Formula Recall Lawsuit Parents are now filing ByHeart recall lawsuits alleging that contaminated infant formula caused botulism and other serious illnesses after the company failed to prevent or warn about dangerous manufacturing lapses.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Lawyers Propose Plans for Bard PowerPort Lawsuit Bellwether Trials in Federal MDL Plaintiffs and defendants suggest an initial pool of 48 Bard PowerPort lawsuits be selected as part of an initial discovery pool, which will be prepared for a series of early trial dates in the federal Multidistrict Litigation (MDL) November 17, 2023 Irvin Jackson Add Your Comments In advance of a case management conference held this week, lawyers involved in federal Bard PowerPort lawsuits outlined competing proposals for selecting a small group of cases that will be prepared for early trial dates, to help gauge the strengths and weaknesses of claims that allege the port catheters are defectively designed, and prone to fracture, fail or cause infections. Over the past few months, Becton, Dickinson & Co., and its Bard subsidiaries have faced a rapidly growing number of product liability lawsuits brought throughout the federal court system, each raising similar allegations that plaintiffs experienced complications from Bard PowerPort or similar Bard implanted port catheter systems, which are placed below the skin to provide easy access for the delivery of medications, such as chemotherapy. The Bard PowerPorts consist of an injection site where a needle is inserted, as well as a polyurethane catheter tube that carries the drug into the blood vessel. Plaintiffs maintain that they have each suffered different injuries due to the same design problems with the port-a-cath, indicating that the material is prone to degrade over time, allowing bacteria to develop or small pieces top break off. Port Catheter Lawsuit DID YOU OR A LOVED ONE RECEIVE AN IMPLANTABLE PORT CATHETER? Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Port Catheter Lawsuit DID YOU OR A LOVED ONE RECEIVE AN IMPLANTABLE PORT CATHETER? Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Given common questions of fact and law raised in the claims, the U.S. Judicial Panel on Multidistrict Litigation (JPML) decided in September to centralize the lawsuits before U.S. District Judge David G. Campbell, in the U.S. District Court for the District of Arizona, for coordinated discovery and bellwether trials, which will test allegations that design defects caused the Bard port catheters to fracture and fail, resulting in severe infections, blood clots and other life-threatening injuries. Bard PowerPort Lawsuit Proposed Bellwether Trial Plan Judge Campbell held a case status conference on Thursday, November 16, to discuss progress made on early issues in the litigation and plans for the future management of the litigation. At the direction of the Court, the attorneys submitted a joint memorandum (PDF) on November 9, outlining issues that would be addressed at the conference, including a proposal for a bellwether trial plan in the Bard PowerPort litigation. The plan calls for the parties to exchange a list of 24 representative cases each, for a total of 48, by July 1, 2024, which will make up the initial plaintiff pool. Following an initial discovery process, the parties will select 15 of those cases for inclusion in Discovery Group 1 by December 17, 2024, with each party picking five cases, and the last five cases being selected jointly. However, plaintiffs and defendants disagree on the number of bellwether trials which should be held, and whether those trials can include multiple plaintiffs at the same time. Plaintiffs argue that 10 bellwether trials should be held to provide an adequate reading of how juries will interpret evidence and testimony likely to be presented in trials throughout the litigation. They also say holding trials that involve multiple plaintiffs will increase the number of data points both parties can use to form the basis of a settlement agreement. The manufacturers indicate that the court should only schedule seven bellwether trials, saying 10 is too burdensome. They also object to the idea of consolidated trials involving multiple plaintiffs. However, defendants did acknowledge in the memorandum that they will not seek to have the cases dismissed on federal preemption grounds, and will not challenge whether plaintiffs have sufficiently pleaded for their claims. The process for selecting of the 15 discovery pool cases will be covered in future case management orders, the memorandum indicates. While the outcomes of these early bellwether trials will not have any impact on other claims pending in the MDL, they will be closely watched by lawyers and will likely have a substantial impact on the amount of Bard PowerPort settlements the manufacturer may offer to avoid each claim being separately remanded for trial in U.S. District Courts nationwide. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Bard, Becton Dickinson, Catheter, Deep Vein Thrombosis, Embolism, PowerPort Find Out If You Qualify for Port Catheter Compensation More Bard PowerPort Lawsuit Stories More Than 2,500 Bard Powerport Lawsuits Filed in Federal Courts Nationwide December 5, 2025 Six Bard PowerPort Lawsuits Will Go Before Juries Between May 2026 and Feb. 2027 November 26, 2025 Bard PowerPort Lawsuit MDL Tops 2,000 Cases September 17, 2025 0 Comments CommentsThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Dupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (Posted: yesterday) An Illinois woman diagnosed with stage IV cutaneous T-cell lymphoma (CTCL) after two years of Dupixent injections has filed a lawsuit against the drug manufacturers. MORE ABOUT: DUPIXENT LAWSUITLawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025)Drug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (12/02/2025) Ozempic, Wegovy Vision Loss Lawsuits Sent to Stomach Injury Judge, as Separate MDL (Posted: 2 days ago) All Ozempic and Wegovy vision loss lawsuits have been consolidated before the same federal judge overseeing related claims alleging stomach paralysis linked to the medications. MORE ABOUT: OZEMPIC LAWSUITOzempic, Mounjaro Side Effects May Increase Risk of Cough: Study (12/03/2025)Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (11/26/2025)Ozempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025) Depo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (Posted: 3 days ago) The FDA has approved an update to the Depo-Provera drug label to include a warning of the risks of meningioma. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)Court To Weigh Evidence That Depo-Provera Causes Meningioma Tumors in Mid-2026 (12/08/2025)Depo-Provera Lawsuit MDL Status Hearings Scheduled Throughout 2026 (12/01/2025)
Dupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (Posted: yesterday) An Illinois woman diagnosed with stage IV cutaneous T-cell lymphoma (CTCL) after two years of Dupixent injections has filed a lawsuit against the drug manufacturers. MORE ABOUT: DUPIXENT LAWSUITLawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025)Drug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (12/02/2025)
Ozempic, Wegovy Vision Loss Lawsuits Sent to Stomach Injury Judge, as Separate MDL (Posted: 2 days ago) All Ozempic and Wegovy vision loss lawsuits have been consolidated before the same federal judge overseeing related claims alleging stomach paralysis linked to the medications. MORE ABOUT: OZEMPIC LAWSUITOzempic, Mounjaro Side Effects May Increase Risk of Cough: Study (12/03/2025)Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (11/26/2025)Ozempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025)
Depo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (Posted: 3 days ago) The FDA has approved an update to the Depo-Provera drug label to include a warning of the risks of meningioma. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)Court To Weigh Evidence That Depo-Provera Causes Meningioma Tumors in Mid-2026 (12/08/2025)Depo-Provera Lawsuit MDL Status Hearings Scheduled Throughout 2026 (12/01/2025)